Dr. Janelle Darby | Gynecologic Oncology | Best Researcher Award
Assistant Professor, at Atrium Health Wake Forest Baptist Medical Center, United States
Dr. Janelle Pakish Darby, MD, MS, is an accomplished Assistant Professor in the Department of Obstetrics and Gynecology at the Wake Forest School of Medicine. She earned her MD from the University of Washington School of Medicine and a Master of Science from the University of Texas Health Science Center at Houston. Dr. Darby’s research focuses on gynecologic oncology, specifically endometrial cancer, with a notable emphasis on the immune microenvironment of microsatellite instable endometrial cancer. Her academic journey includes postdoctoral training at prestigious institutions like Dartmouth-Hitchcock Medical Center and MD Anderson Cancer Center. Throughout her career, Dr. Darby has received numerous honors, including the Felix Rutledge Fellow award and the Best Abstract on Gynecologic Oncology Award. She is actively involved in advancing medical education through her innovative work in developing gynecologic oncology curricula and her participation in leadership programs such as the Association of Professors of Gynecology and Obstetrics (APGO) Academic Scholars and Leaders Program. Dr. Darby’s contributions to both research and education make her a distinguished figure in her field.
Professional Profile
Education 🎓
Dr. Janelle Pakish Darby earned her Bachelor of Arts in Biology from the University of Pennsylvania in 2006, before pursuing her MD at the University of Washington School of Medicine in 2010. She further advanced her academic credentials by obtaining a Master of Science from the University of Texas Health Science Center at Houston in 2016. Her research thesis, titled “The Immune Microenvironment of Microsatellite Instable Endometrial Cancer,” reflects her academic dedication to advancing the understanding of cancer biology.
Experience 💼
Dr. Darby is currently an Assistant Professor at the Wake Forest School of Medicine in the Department of Obstetrics and Gynecology, where she has been shaping the next generation of medical professionals since 2018. Prior to this role, she completed a residency in Obstetrics and Gynecology at Dartmouth-Hitchcock Medical Center and a fellowship in Gynecologic Oncology at MD Anderson Cancer Center. Her professional journey is a testament to her commitment to patient care and academic excellence.
Research Interest 🔬
Dr. Darby’s research primarily focuses on gynecologic oncology, with a particular interest in endometrial cancer. She has extensively studied the immune microenvironment of cancer, specifically microsatellite instable endometrial cancer, contributing to the growing body of knowledge surrounding cancer immunology. Her expertise in cancer diagnostics and treatment positions her as a leader in the field, working toward improving patient outcomes through novel approaches in gynecologic oncology.
Award 🏅
Dr. Darby has received numerous honors throughout her career. She was awarded the SPARX/CHAP Participation Award in 2008 for her commitment to community health, followed by the Felix Rutledge Fellow recognition at MD Anderson Cancer Center in 2012. In 2013, she was awarded the Best Abstract on Gynecologic Oncology Award at the AAGL Global Congress on Minimally Invasive Gynecology, underscoring her academic excellence and contributions to the field of gynecology.
Top Noted Publication 📑
Title: A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers
Authors:
Laurel K. Berry
Ashok K. Pullikuth
Kristen L. Stearns
Julia Chifman
Lance David Miller
Journal: Journal of Translational Medicine
Year of Publication: 2024
Citations: Not yet available (as of the current year)
Index: Journal of Translational Medicine
Conclusion
Dr. Janelle Pakish Darby is a highly qualified and dedicated professional with a solid track record in academic and clinical research. Her work in gynecologic oncology and her involvement in education and leadership make her a strong contender for the Best Researcher Award. While her research output and funding could be further enhanced, her expertise, leadership, and potential for future contributions to cancer research position her as an exceptional candidate. Expanding her research network and publications would solidify her standing as a leader in her field.